Cargando…

Construction of quality of life change patterns: example in oncology in a phase III therapeutic trial (FFCD 0307)

OBJECTIVE: Quality of life data in cancerology are often difficult to summarize due to missing data and difficulty to analyze the pattern of evolution in different groups of patients. The aim of this work was to apply a new methodology to construct Quality of Life (QoL) change patterns within patien...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nuemi, Gillles, Devilliers, Hervé, Le Malicot, Karine, Guimbaud, Rosine, Lepage, Côme, Quantin, Catherine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4578418/ https://www.ncbi.nlm.nih.gov/pubmed/26391356 http://dx.doi.org/10.1186/s12955-015-0342-1

Ejemplares similares

Evaluation of the relevance of the growth modulation index (GMI) from the FFCD 0307 randomized phase III trial comparing the sequence of two chemotherapeutic regimens
por: du Rusquec, P., et al.
Publicado: (2023)

FFCD-1004 Clinical Trial: Impact of Cytidine Deaminase Activity on Clinical Outcome in Gemcitabine-Monotherapy Treated Patients
por: Serdjebi, Cindy, et al.
Publicado: (2015)

A data mining approach for grouping and analyzing trajectories of care using claim data: the example of breast cancer
por: Jay, Nicolas, et al.
Publicado: (2013)

Phase II/III multicentre randomised controlled trial evaluating a strategy of primary surgery and adjuvant chemotherapy versus peri-operative chemotherapy for resectable gastric signet ring cell adenocarcinomas – PRODIGE 19 – FFCD1103 – ADCI002
por: Piessen, Guillaume, et al.
Publicado: (2013)

Management of digestive cancers during the COVID-19 second wave: A French intergroup point of view (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, SFR)
por: Tougeron, David, et al.
Publicado: (2021)

P03.07. Integrating Acupuncture and Massage Into the Chemotherapy Infusion Setting
por: Seppelfrick, Dianne, et al.
Publicado: (2013)

COVID-19 epidemic: Proposed alternatives in the management of digestive cancers: A French intergroup clinical point of view (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, SFR)
por: Di Fiore, Frederic, et al.
Publicado: (2020)

EHMTI-0307. Chronification of migraine: a clinical and voxel-based morphometry study
por: Yu, S, et al.
Publicado: (2014)

P.0307 Coping with stress and alcohol consumption during covid-19 lockdown
por: Merlo, A., et al.
Publicado: (2021)

Efficacy of donepezil for the treatment of oxaliplatin-induced peripheral neuropathy: DONEPEZOX, a protocol of a proof of concept, randomised, triple-blinded and multicentre trial
por: Kerckhove, Nicolas, et al.
Publicado: (2022)

P03.07. Thematic analysis of resident application essays for a nutrition education program
por: Graham, R, et al.
Publicado: (2012)

A Novel Azaphilone Muyophilone A From the Endophytic Fungus Muyocopron laterale 0307-2
por: Yuan, Chao, et al.
Publicado: (2021)

Impact of G-CSF Prophylaxis on Chemotherapy Dose-Intensity, Link Between Dose-Intensity and Survival in Patients with Metastatic Pancreatic Adenocarcinoma
por: Canton, Clémence, et al.
Publicado: (2022)

Safety of FOLFIRI + Durvalumab +/− Tremelimumab in Second Line of Patients with Advanced Gastric Cancer: A Safety Run-In from the Randomized Phase II Study DURIGAST PRODIGE 59
por: Evrard, Camille, et al.
Publicado: (2022)

Should we screen for colorectal cancer in people aged 75 and over? A systematic review - collaborative work of the French geriatric oncology society (SOFOG) and the French federation of digestive oncology (FFCD)
por: Guittet, Lydia, et al.
Publicado: (2023)

Multicentre phase II trial of capecitabine plus oxaliplatin (XELOX) in patients with advanced hepatocellular carcinoma: FFCD 03-03 trial
por: Boige, V, et al.
Publicado: (2007)

Impact of time-varying cumulative bevacizumab exposures on survival: re-analysis of data from randomized clinical trial in patients with metastatic colo-rectal cancer
por: Guilloteau, Adrien, et al.
Publicado: (2021)

Intra-arterial hepatic beads loaded with irinotecan (DEBIRI) with mFOLFOX6 in unresectable liver metastases from colorectal cancer: a Phase 2 study
por: Pernot, Simon, et al.
Publicado: (2020)

Induction cisplatin–irinotecan followed by concurrent cisplatin–irinotecan and radiotherapy without surgery in oesophageal cancer: multicenter phase II FFCD trial
por: Michel, P, et al.
Publicado: (2006)

Microstructure Influence of SACX0307-TiO(2) Composite Solder Joints on Thermal Properties of Power LED Assemblies
por: Skwarek, Agata, et al.
Publicado: (2020)

PA03.07. A clinical comparative study of Matra Vasti and Vaitran Vasti in the treatment of Gridhrasi w.s.r to Sciatica
por: Gupta, Charu, et al.
Publicado: (2013)

OA03.07. A comparative clinical study to evaluate the therapeutic effect of shivagutika in patients with H.I.V infection
por: Anil, L Abhishek, et al.
Publicado: (2013)

Artificial intelligence-guided tissue analysis combined with immune infiltrate assessment predicts stage III colon cancer outcomes in PETACC08 study
por: Reichling, Cynthia, et al.
Publicado: (2020)

Primary Gastrointestinal Follicular Lymphomas: A Prospective Study of 31 Patients with Long-term Follow-up Registered in the French Gastrointestinal Lymphoma Study Group (GELD) of the French Federation of Digestive Oncology (FFCD)
por: Matysiak-Budnik, Tamara, et al.
Publicado: (2022)

Combination 5-fluorouracil, folinic acid and cisplatin (LV5FU2-CDDP) followed by gemcitabine or the reverse sequence in metastatic pancreatic cancer: final results of a randomised strategic phase III trial (FFCD 0301)
por: Dahan, Laetitia, et al.
Publicado: (2010)

Treatment-free remission in chronic myeloid leukemia patients treated front-line with nilotinib: 10-year follow-up of the GIMEMA CML 0307 study
por: Gugliotta, Gabriele, et al.
Publicado: (2022)

Perioperative Cetuximab with Cisplatin and 5-Fluorouracil in Esogastric Adenocarcinoma: A Phase II Study
por: Gronnier, Caroline, et al.
Publicado: (2023)

Avelumab vs Standard Second-Line Chemotherapy in Patients With Metastatic Colorectal Cancer and Microsatellite Instability: A Randomized Clinical Trial
por: Taïeb, Julien, et al.
Publicado: (2023)

Psychotherapeutic practice in paediatric oncology: four examples
por: Oppenheim, D, et al.
Publicado: (2000)

Is Gestational Diabetes Mellitus a Risk Factor of Maternal Breast Cancer? A Systematic Review of the Literature
por: Simon, Julien, et al.
Publicado: (2021)

Radiomics in Oncology III
por: Zerunian, Marta, et al.
Publicado: (2023)

Monitoring Monoclonal Antibody Delivery in Oncology: The Example of Bevacizumab
por: Nugue, Guillaume, et al.
Publicado: (2013)

Matching methods in precision oncology: An introduction and illustrative example
por: Weymann, Deirdre, et al.
Publicado: (2020)

Development and Validation of a Lateral Flow Immunoassay for Rapid Detection of NDM-Producing Enterobacteriaceae
por: Boutal, Hervé, et al.
Publicado: (2017)

Updated Trends in Imaging Practices for Pancreatic Neuroendocrine Tumors (PNETs): A Systematic Review and Meta-Analysis to Pave the Way for Standardization in the New Era of Big Data and Artificial Intelligence
por: Partouche, Ephraïm, et al.
Publicado: (2021)

Docetaxel, Cisplatin, and 5-fluorouracil (DCF) chemotherapy in the treatment of metastatic or unresectable locally recurrent anal squamous cell carcinoma: a phase II study of French interdisciplinary GERCOR and FFCD groups (Epitopes-HPV02 study)
por: Kim, Stefano, et al.
Publicado: (2017)

Creation of clinical algorithms for decision-making in oncology: an example with dose prescription in radiation oncology
por: Dennstädt, Fabio, et al.
Publicado: (2021)

Increased Risk of Hospitalization for Pancreatic Cancer in the First 8 Years after a Gestational Diabetes Mellitus regardless of Subsequent Type 2 Diabetes: A Nationwide Population-Based Study
por: Simon, Julien, et al.
Publicado: (2021)

Neoadjuvant FOLFOX 4 versus FOLFOX 4 with Cetuximab versus immediate surgery for high-risk stage II and III colon cancers: a multicentre randomised controlled phase II trial – the PRODIGE 22 - ECKINOXE trial
por: Karoui, Mehdi, et al.
Publicado: (2015)

Health technology assessment: oncology drugs with orphan designation as an example
por: Wild, Claudia
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_vfrpl6v2mp78fra5mgplerob99